Using AI to improve healthcare communication and documentation for better care and greater revenue.

Advise biotechnology companies and NGOs on translational research, product development, go-to-market and funding strategies.• Advised small biotech R&D team on new product categories and nondilutive funding opportunities, resulting in 3 new products launched. • Managed assay development team and advised engineering team to develop COVID antigen detection platform resulting in 1000x signal to noise improvement. • Educated major tech company’s sales force about incorporating AI at different stages of drug development.• Served as expert external reviewer and performed SWOT analyses on grant applications for a major NGO.

Responsible for driving product development, filling R&D pipeline, and prioritizing resources to maximize ROI. Directly managed a team of 5 and led multi-disciplinary teams to demonstrate technical and market feasibility for ultimate commercial partner handoff.• Developed understanding of healthcare and agricultural systems, identified critical issues, and drove in-house cross-functional teams and external partners to develop commercially viable solutions.• Presented product viability, risk, mitigation and overall progress to executive stakeholders, including Bill Gates, to secure approval and funding.• Identified, forged, and managed global strategic partnerships with academics, private corporations, NGOs, and applied research groups.

Responsible for technical output of up to 18 scientists and engineers that performed 9 concurrent discovery and translational R&D projects with cumulative annual budget exceeding $6M. Identified, forged, and managed global strategic partnerships. • Achieved 2 commercialized products, 10 published manuscripts, 3 granted and 1 pending patents, and 12 academic and 7 commercial collaborations. • Grew life sciences R&D team from 3 staff scientists to >40 including, principal, senior and research scientists.• Oversaw in-house assay development and closely collaborated with commercial partner on hardware development to develop point-of-care HPV diagnostic. Responsible for project from conception and partner selection until just prior to verification and validation.• Identified gaps in cold chain management of biological materials and codeveloped 2 solutions; key contributor to licensing negotiations, commercial technology transfer and obtaining regulatory approval. • Oversaw infrastructure including the build-out and operations of a new wet laboratory that served up to 70 scientists and diverse projects.

Product Manager for protein-related projects which resulted in 15 commercialized, 1 granted patent and 5 published manuscripts. Drove products from ideation through development, scale-up and hand-off to manufacturing and quality.Developed ATX-Red, an in vivo imaging agent and potential companion diagnostic that detects and monitors tumors and winner of 2007 2nd Place Utah Biotechnology Innovation Award.Wrote and was awarded Phase I & II Small Business innovation Research (SBIR) grants from both NIH and NSF totaling $827,696.

Investigated molecular mechanisms underlying Huntington’s disease symptoms using proteomic identification of aberrantly palmitoylated proteins in a mouse model.

Studied the protein folding mechanism of the E. coli chaperone GroEL. Applied a broad range of biochemical, biophysical, and molecular biological techniques with strong emphases on recombinant protein purification, bioconjugation, and characterization.